The Role of TLR4 on Lipid-Induced Insulin Resistance

Trial Profile

The Role of TLR4 on Lipid-Induced Insulin Resistance

Suspended
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Eritoran (Primary) ; Soya oil emulsion
  • Indications Septic shock
  • Focus Therapeutic Use
  • Acronyms Eritoran1
  • Most Recent Events

    • 06 Sep 2017 Status changed from recruiting to suspended.
    • 15 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 26 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top